Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Don Sun
Institution:
Janssen Research & Development (United States)
Observed institutions:
Alcatel-Lucent (France),
Janssen Research & Development (United States)
OpenAlex ID:
A5114009636
Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus
2001
·
Irene Georgakoudi
, Brian C. Jacobson
, et al.
·
Gastroenterology
·
473
PDF
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co‐transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases
2019
·
Lu Wang
, Erica A. Voss
, et al.
·
Pharmacoepidemiology and Drug Safety
·
59
PDF
Renal safety of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, in patients with type 2 diabetes mellitus
2017
·
Mehul Desai
, Yshai Yavin
, et al.
·
Diabetes Obesity and Metabolism
·
27
PDF
Statistics in the Physical Sciences and Engineering
2001
·
Diane Lambert
, Doug Nychka
, et al.
·
Monographs on statistics and applied probability
·
1
Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment
2021
·
Rao N.V.S. Mamidi
, Damayanthi Devineni
, et al.
·
Annals of Internal Medicine
Abstract 24: Diabetic Ketoacidosis in Patients with Type 2 Diabetes Treated with Sodium Glucose Co-transporter 2 Inhibitors versus Other Antihyperglycemic Agents: An Observational Study of Four US Administrative Claims Databases
2019
·
Lu Wang
, Erica A Voss
, et al.
·
Circulation Cardiovascular Quality and Outcomes
Show more works
View as search
Works count:
6
Citation count:
560
H-index:
3
I10-index:
3
Year
Topic
Type